MICREOS

Micreos is a platform biotech company focused on discovering and developing recombinant proteins for chronic Dermatology / Oncology conditions... Micreos is specialised in dermatology and derm-oncology with our 2 lead development candidates focused on eliminating Staphylococcus aureus (S. aureus) colonisation in patients living with Atopic Dermatitis (AD) and Cutaneous T-cell lymphoma (CTCL)... Our vision is to fully maximise the potential of our engineered endolysin and antimicrobial vectors platforms to transform the treatment of a broader range of bacteria-induced diseases.

Registration numbers: CH-170.3.046.649-1 (W)

Primary location: Baar